Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
W&T Offshore
WTI
$522M
| $1.81M | ﹤0.01% |
683,663
+259,234
| +61% | +$741K |
|
2627
Holley
HLLY
$332M
| $1.81M | ﹤0.01% |
405,205
+1,417
| +0.4% | +$6.47K |
|
2628
Universal Technical Institute
UTI
$2.28B
| $1.77M | ﹤0.01% |
111,071
+21,917
| +25% | +$318K |
|
2629
Monte Rosa Therapeutics
GLUE
$1.3B
| $1.77M | ﹤0.01% |
250,582
+5,020
| +2% | +$29.8K |
|
2630
Digital Turbine
APPS
$1.09B
| $1.76M | ﹤0.01% |
673,326
-106,926
| -14% | -$454K |
|
2631
Funko
FNKO
$323M
| $1.76M | ﹤0.01% |
281,627
+5,575
| +2% | +$39.1K |
|
2632
Omeros
OMER
$909M
| $1.74M | ﹤0.01% |
504,369
+35,195
| +8% | +$134K |
|
2633
AMC Entertainment Holdings
AMC
$2.54B
| $1.72M | ﹤0.01% |
463,700
+112,841
| +32% | +$503K |
|
2634
Citizens Financial Services
CZFS
$368M
| $1.72M | ﹤0.01% |
35,765
+3,185
| +10% | +$162K |
|
|
TWKS
2635
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.72M | ﹤0.01% |
681,758
-55,858
| -8% | -$214K |
|
2636
SES AI
SES
$218M
| $1.72M | ﹤0.01% |
1,026,550
-53,733
| -5% | -$80.6K |
|
|
NXDT
2637
NexPoint Diversified Real Estate Trust
NXDT
$244M
| $1.72M | ﹤0.01% |
260,630
+8,645
| +3% | +$57.5K |
|
|
FRGE
2638
DELISTED
Forge Global Holdings
FRGE
| $1.71M | ﹤0.01% |
59,220
+2,143
| +4% | +$66.9K |
|
2639
Neumora Therapeutics
NMRA
$304M
| $1.71M | ﹤0.01% |
124,542
-5,370
| -4% | -$86.8K |
|
2640
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.37B
| $1.71M | ﹤0.01% |
13,058
-605
| -4% | -$75.5K |
|
2641
FLEX LNG
FLNG
$1.67B
| $1.7M | ﹤0.01% |
66,843
-1,978
| -3% | -$54.2K |
|
|
PSTX
2642
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.7M | ﹤0.01% |
532,593
+22,830
| +4% | +$76.1K |
|
2643
Vanguard Financials ETF
VFH
$13.6B
| $1.69M | ﹤0.01% |
16,500
-5,142
| -24% | -$493K |
|
2644
EverCommerce
EVCM
$2.12B
| $1.68M | ﹤0.01% |
178,093
+3,140
| +2% | +$30.6K |
|
|
CIO
2645
DELISTED
City Office REIT
CIO
| $1.67M | ﹤0.01% |
321,076
-3,294
| -1% | -$16.6K |
|
2646
American Well
AMWL
$180M
| $1.67M | ﹤0.01% |
102,945
+19,102
| +23% | +$410K |
|
2647
FTAI Infrastructure
FIP
$405M
| $1.67M | ﹤0.01% |
265,137
-5,050
| -2% | -$23.4K |
|
2648
Regional Management Corp
RM
$320M
| $1.66M | ﹤0.01% |
68,686
-915
| -1% | -$22K |
|
2649
NET Power
NPWR
$133M
| $1.66M | ﹤0.01% |
145,832
+11,831
| +9% | +$107K |
|
2650
Kiniksa Pharmaceuticals
KNSA
$5.73B
| $1.66M | ﹤0.01% |
84,155
-72,586
| -46% | -$1.42M |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.